FDA Approves New Treatment for Chest Pain: "The Food and Drug Administration (FDA) announced today the approval of Ranexa (ranolazine), a new drug for the treatment of chronic angina. Ranexa, a new molecular entity (NME), is the first drug approved to treat chronic angina in over ten years."
Wednesday, February 01, 2006
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment